Philips quarterly sales soared during the pandemic

April 26, 2021
Philips quarterly sales soared during the pandemic

The company lifted its 2021 outlook amid better-than-expected quarterly figures

The Dutch health technology company Philips posted quarterly earnings that topped expectations, as the COVID-19 pandemic boosted demand for hospital equipment and personal health appliances.

Philips announced that its core earnings jumped 74% in Q1 2021 to €362 million, while its comparable sales (revenue generated by a retail location in the most recent accounting compared to the revenue generated during the same period in the past) went up 9%, beating expectations. According to CEO Frans van Houten: “Our performance gained momentum with a strong sales growth and profitability improvement, with all business segments and markets contributing.” The markets were looking for €326 million in earnings and a 6% rise in comparable sales.

However, its net profit remained unchanged at €40 million.

For the futures, Philips expects its comparable sales to grow by “low-to-mid-single-digit” in 2021.

The market’s reaction wasn’t a positive one, given that at the moment of writing, during the pre-market session, Philips stock price is trading more than 3% lower.


This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.
This information is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of

Recently Added

Most Affected Instruments

philips chart